Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
TABLET
**POSOLOGY AND METHOD OF ADMINISTRATION** Follow the doctor’s prescription. For reference: Adults: 1 or 2 tablets 3 times a day.
ORAL
Medical Information
**THERAPEUTIC INDICATIONS** **Gastroenterology:** Polymorphous symptoms of the gastro-intestinal tract, grouped under the irritable bowel syndrome entity or functional digestive disorders, in particular abdominal pain and cramps, spasms, flatulence, diarrhea and/or constipation.
**CONTRAINDICATIONS – DRUG INTERACTIONS** None.
A03AA05
trimebutine
Manufacturer Information
PFIZER PRIVATE LIMITED
FARMEA
Active Ingredients
Documents
Package Inserts
Package Insert.doc
Approved: November 28, 2022